Quote:

---

"...we believe there is an opportunity to generate meaningful (LymPro) revenues that will offset development costs in other areas until such a point where we are able to realize revenue generation in other categories..."

---

LymPro sale or diagnostics division spin-off would qualify as an opportunity. Sale proceeds or capital raise through spin-off would qualify as revenues.

What's the issue here? There is none. If the recent business update call didn't spell it out for you, you're not as bright as I thought. Seriously.